Improving the activity of BH3 mimetic venetoclax: a case study

Andrew Wei, MBBS, PhD, FRACP, FRCPA, from Monash University, Melbourne, Australia, discusses clinical trials investigating the effect of BH3 mimetic drugs, such as venetoclax, on acute myeloid leukemi... Author: VJHemOnc Added: 06/11/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts